In this episode, Sam Ulin, Debbie Zhuang, and Matthew Murphy dive into the strategic heart of biotech platform assessment. From evaluating technology differentiation to navigating investment shifts and manufacturing trends, the conversation is fast-paced, unscripted, and packed with insight.


Enter Information to Begin Download

By providing my email address, I agree to ClearView's online policies

  • This field is for validation purposes and should be left unchanged.